Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to -$1.1 billion.

  • Myriad Genetics' Retained Earnings fell 5606.89% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 5606.89%. This contributed to the annual value of -$756.8 million for FY2024, which is 2022.24% down from last year.
  • Myriad Genetics' Retained Earnings amounted to -$1.1 billion in Q3 2025, which was down 5606.89% from -$1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Retained Earnings peaked at -$246.6 million during Q3 2021, and registered a low of -$1.1 billion during Q3 2025.
  • Its 5-year average for Retained Earnings is -$539.8 million, with a median of -$537.0 million in 2023.
  • Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 12489.45% in 2021, then plummeted by 307.69% in 2022.
  • Myriad Genetics' Retained Earnings (Quarter) stood at -$254.2 million in 2021, then crashed by 44.06% to -$366.2 million in 2022, then tumbled by 71.9% to -$629.5 million in 2023, then dropped by 20.22% to -$756.8 million in 2024, then plummeted by 47.3% to -$1.1 billion in 2025.
  • Its last three reported values are -$1.1 billion in Q3 2025, -$1.1 billion for Q2 2025, and -$756.9 million during Q1 2025.